Literature DB >> 15897559

Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance.

Sayaka Otake1, Hiroaki Takeda, Yasukuni Suzuki, Tadahisa Fukui, Shinichiro Watanabe, Katsuyoshi Ishihama, Takafumi Saito, Hitoshi Togashi, Tadashi Nakamura, Yuji Matsuzawa, Sumio Kawata.   

Abstract

PURPOSE: Colorectal carcinogenesis is thought to be related to abdominal obesity and insulin resistance. To investigate whether visceral fat accumulation contributes to colorectal carcinogenesis, we examined its accumulation and the levels of the adipose tissue-derived hormone adiponectin in Japanese patients with colorectal adenoma. EXPERIMENTAL
DESIGN: Fifty-one consecutive Japanese patients ages >/=40 years and with colorectal adenoma were subjected to measurement of visceral fat area by computed tomography scanning and plasma adiponectin concentration. The patients also underwent the 75-g oral glucose tolerance test. Insulin resistance was calculated by the homeostasis metabolic assessment (HOMA-IR) method. The controls were 52 Japanese subjects ages >/=40 years and without colorectal polyp. Cigarette smokers and subjects who consumed alcohol (>/=30 g ethanol/d) were excluded.
RESULTS: The patients with colorectal adenoma showed significantly more visceral fat area and significantly less plasma adiponectin concentration in comparison with the controls [odds ratio (OR), 2.19; 95% confidence interval (95% CI), 1.47-3.28; P < 0.001 and OR, 0.24; 95% CI, 0.14-0.41; P < 0.001, respectively] by logistic regression analysis. HOMA-IR index was also associated with colorectal adenoma (OR 2.60; 95% CI, 1.20-5.64; P = 0.040). Visceral fat area and adiponectin were associated with adenoma number (1, 2, >/= 3), the size of the largest adenoma (<10 and >/=10 mm), and adenoma histology (tubular and tubulovillous/villous).
CONCLUSIONS: These results suggest an association of visceral fat accumulation and decreased plasma adiponectin concentration with colorectal adenoma in Japanese patients. This study may offer a new insight to understanding the relationship of colorectal carcinogenesis with abdominal obesity and insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897559     DOI: 10.1158/1078-0432.CCR-04-1868

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  74 in total

1.  Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention Trial.

Authors:  Gerd Bobe; Gwen Murphy; Connie J Rogers; Kenneth W Hance; Paul S Albert; Adeyinka O Laiyemo; Leah B Sansbury; Elaine Lanza; Arthur Schatzkin; Amanda J Cross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  Insulin resistance, central obesity, and risk of colorectal adenomas.

Authors:  Ana Patricia Ortiz; Cheryl L Thompson; Amitabh Chak; Nathan A Berger; Li Li
Journal:  Cancer       Date:  2011-08-25       Impact factor: 6.860

3.  Adiponectin receptors are downregulated in human gastric cancer.

Authors:  Kensuke Otani; Joji Kitayama; Takao Kamei; Daisuke Soma; Hideyo Miyato; Toshimasa Yamauchi; Takashi Kadowaki; Hirokazu Nagawa
Journal:  J Gastroenterol       Date:  2010-03-25       Impact factor: 7.527

Review 4.  Body mass index and colon cancer screening: the road ahead.

Authors:  Kanwarpreet Tandon; Mohamad Imam; Bahaa Eldeen Senousy Ismail; Fernando Castro
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 5.  Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

Authors:  Hanuma Kumar Karnati; Manas Kumar Panigrahi; Yazhou Li; David Tweedie; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

6.  Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation.

Authors:  A Young Kim; Yun Sok Lee; Kang Ho Kim; Jae Ho Lee; Hee Kyu Lee; Su-Hwa Jang; Seong-Eun Kim; Gha Young Lee; Joo-Won Lee; Sung-Ae Jung; Hee Yong Chung; Sunjoo Jeong; Jae Bum Kim
Journal:  Mol Endocrinol       Date:  2010-05-05

7.  Percent Body Fat Measured by Bioelectrical Impedance is Not Associated with Colorectal Adenoma Status.

Authors:  David J Frantz; Seth D Crockett; Joseph A Galanko; Robert S Sandler
Journal:  J Gastroenterol Hepatol Res       Date:  2013

8.  Effect of adiponectin and ghrelin on apoptosis of Barrett adenocarcinoma cell line.

Authors:  Peter C Konturek; Grzegorz Burnat; Tilman Rau; Eckhart G Hahn; Stanislaw Konturek
Journal:  Dig Dis Sci       Date:  2007-09-01       Impact factor: 3.199

9.  Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study.

Authors:  Daniele Campa; Barbara Pardini; Alessio Naccarati; Ludmila Vodickova; Jan Novotny; Verena Steinke; Nils Rahner; Elke Holinski-Feder; Monika Morak; Hans K Schackert; Heike Görgens; Judith Kötting; Beate Betz; Matthias Kloor; Christoph Engel; Reinhard Büttner; Peter Propping; Asta Försti; Kari Hemminki; Roberto Barale; Pavel Vodicka; Federico Canzian
Journal:  BMC Gastroenterol       Date:  2010-09-28       Impact factor: 3.067

10.  Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia.

Authors:  Shuichiro Yamamoto; Toru Nakagawa; Yumi Matsushita; Suzushi Kusano; Takeshi Hayashi; Masataka Irokawa; Takatoshi Aoki; Yukunori Korogi; Tetsuya Mizoue
Journal:  Diabetes Care       Date:  2009-10-16       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.